Abingworth Management Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Abingworth Management Inc
CRD #157466
SEC #801-73401
CIK #0001291892, 0001397144
AUM
Employees 24 (58% Investors, 0% Brokers)
Phone650-926-0600
Address3000 Sand Hill Road
Menlo Park, CA 94025
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
20001600120080040002009201420192025
CIK Period
0001291892 0001397144
Sector Form 13F Holdings Value ($B)
Medline Inc 8.3
Standardaero Inc 2.2
Phathom Pharmaceuticals Inc 0.0
PONY AI Inc 0.0
Invitation Homes Inc 0.0
U-Store-It Trust 0.0
Homology Medicines Inc 0.0
Getty Images Holdings Inc 0.0
Spruce Biosciences Inc 0.0
Forward Air Corp 0.0
Restorbio Inc 0.0
Krispy Kreme Inc 0.0
Reneo Pharmaceuticals Inc 0.0
Amplitude Healthcare Acquisition Corp 0.0
Freedom Acquisition I Corp 0.0
Heartflow Inc 0.0
Aeglea Biotherapeutics Inc 0.0
N-Able Inc 0.0
Max-1 Acquisition Corp 0.0
Robinhood Markets Inc 0.0
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold ($M) AUM ($M)
HF Abingworth Bioequities Master Fund Limited 2012-03-30 80.8
VC Abingworth BioVentures IIIA LP 2012-03-30 16.4
VC Abingworth BioVentures IIIB LP 2012-03-30 10.0
VC Abingworth BioVentures IIIC LP 2012-03-30 6.0
VC Abingworth BioVentures III Executives LP 2012-03-30 0.3
VC Abingworth BioVentures II SICAV in Voluntary Liquidation 2012-03-30 2.8
VC Abingworth BioVentures IV Executives LP 2012-03-30 0.5
VC Abingworth BioVentures IV LP 2012-03-30 57.1
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 1,731.9
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 9 1,731.9
By Discretionary
Discretionary 9 1,731.9
Non-Discretionary 0 0.0
Total 9 1,731.9
By Non-United States Persons
Non-United States Persons 1,731.9
United States Persons 0.0
Total 9 1,731.9
EDGAR Form CIK 2011 - 2026
3 [0001291892]
4 [0001291892]
SC 13D [0001291892]
13F-HR [0001397144]
13F-NT [0001397144]
3 [0001397144]
4 [0001397144]
SC 13D [0001397144]
SC 13G [0001397144]
Form 13D/13G Filer Form 13D/13G Subject Filed
Abingworth LLP Hillevax Inc [2022-05-13]
Abingworth LLP Jasper Therapeutics Inc [2021-10-04]
Abingworth LLP Effector Therapeutics Inc [2021-09-03]
Abingworth LLP Vera Therapeutics Inc [2021-05-24]
Abingworth LLP Reneo Pharmaceuticals Inc [2021-04-20]
Abingworth LLP Adicet Bio Inc [2021-03-08]
Abingworth LLP Adicet Bio Inc [2021-03-08]
Abingworth LLP Vaxcyte Inc [2021-02-16]
Abingworth LLP Spruce Biosciences Inc [2020-10-16]
Abingworth LLP Nucana PLC [2020-09-28]
View All
Form 3/4/5 Subject 2011 - 2026
Carlyle Genesis UK LLC
Carlyle Holdings I GP Sub L.L.C.
Carlyle Investment Management LLC
Carlyle Group Inc.
Carlyle Holdings I GP Inc.
CG Subsidiary Holdings L.L.C.
Abingworth Bioventures VII LP
Carlyle Holdings I L.P.
Jasper Therapeutics, Inc.
Abingworth LLP
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com